Novavax, Inc. (NVAX)
7.63
-0.39
(-4.86%)
USD |
NASDAQ |
Apr 02, 14:41
Novavax Research and Development Expense (TTM) : 338.72M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 12.71B |
| Pfizer Inc. | 10.25B |
| Moderna, Inc. | 2.917B |
| Intellia Therapeutics, Inc. | 379.07M |
| Recursion Pharmaceuticals, Inc. | 425.27M |